154 related articles for article (PubMed ID: 19895176)
21. Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer.
Pujol P; Daurès JP; Brouillet JP; Maudelonde T; Rochefort H; Grenier J
Br J Cancer; 1999 Feb; 79(5-6):909-14. PubMed ID: 10070889
[TBL] [Abstract][Full Text] [Related]
22. Estrogen and progesterone receptors in human breast cancer with concomitant assay of plasma 17beta-estradiol, progesterone, and prolactin levels.
Nagai R; Kataoka M; Kobayashi S; Ishihara K; Tobioka N; Nakashima K; Naruse M; Saito K; Sakuma S
Cancer Res; 1979 May; 39(5):1834-40. PubMed ID: 427816
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels of sex hormones and their relation to risk factors for breast cancer: a cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom).
Verkasalo PK; Thomas HV; Appleby PN; Davey GK; Key TJ
Cancer Causes Control; 2001 Jan; 12(1):47-59. PubMed ID: 11227925
[TBL] [Abstract][Full Text] [Related]
24. Hormonal profiles in lactating and non-lactating women immediately after delivery and their relationship to breast engorgement.
West CP; McNeilly AS
Br J Obstet Gynaecol; 1979 Jul; 86(7):501-6. PubMed ID: 476015
[TBL] [Abstract][Full Text] [Related]
25. Endogenous sex hormones, prolactin, and mammographic features of breast tissue in premenopausal women.
Meyer F; Brisson J; Morrison AS; Brown JB
J Natl Cancer Inst; 1986 Sep; 77(3):617-20. PubMed ID: 3462405
[TBL] [Abstract][Full Text] [Related]
26. [Prolactin and steroid hormones in the blood in local disorders of the lymph-plasma circulation in breast cancer patients].
Berzin SA; Tokar' VN
Sov Med; 1988; (12):16-9. PubMed ID: 3242113
[No Abstract] [Full Text] [Related]
27. Associations of ionizing radiation and breast cancer-related serum hormone and growth factor levels in cancer-free female A-bomb survivors.
Grant EJ; Neriishi K; Cologne J; Eguchi H; Hayashi T; Geyer S; Izumi S; Nishi N; Land C; Stevens RG; Sharp GB; Nakachi K
Radiat Res; 2011 Nov; 176(5):678-87. PubMed ID: 21718103
[TBL] [Abstract][Full Text] [Related]
28. Effects of raloxifene on circulating prolactin and estradiol levels in premenopausal women at high risk for developing breast cancer.
Faupel-Badger JM; Prindiville SA; Venzon D; Vonderhaar BK; Zujewski JA; Eng-Wong J
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1153-8. PubMed ID: 16775175
[TBL] [Abstract][Full Text] [Related]
29. [The antiestrogen tamoxifen in advanced breast cancer (author's transl)].
Margreiter R
Langenbecks Arch Chir; 1980; 351(4):249-62. PubMed ID: 6779066
[TBL] [Abstract][Full Text] [Related]
30. Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women.
Noh JJ; Maskarinec G; Pagano I; Cheung LW; Stanczyk FZ
Breast; 2006 Feb; 15(1):20-8. PubMed ID: 16000251
[TBL] [Abstract][Full Text] [Related]
31. Maternal Pregnancy Hormone Concentrations in Countries with Very Low and High Breast Cancer Risk.
Ganmaa D; Enkhmaa D; Baatar T; Uyanga B; Gantsetseg G; Helde TT; McElrath TF; Cantonwine DE; Bradwin G; Falk RT; Hoover RN; Troisi R
Int J Environ Res Public Health; 2020 Jan; 17(3):. PubMed ID: 32012981
[TBL] [Abstract][Full Text] [Related]
32. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
[TBL] [Abstract][Full Text] [Related]
33. The relation between plasma oestrogen, progesterone and prolactin concentrations and the efficacy of vaginal prostaglandin E2 gel in initiating labour.
MacKenzie IZ; Jenkin G; Bradley S
Br J Obstet Gynaecol; 1979 Mar; 86(3):171-4. PubMed ID: 427057
[TBL] [Abstract][Full Text] [Related]
34. Plasma sex steroid hormones and breast cancer risk in Chinese women.
Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
[TBL] [Abstract][Full Text] [Related]
35. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
36. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J
Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
[TBL] [Abstract][Full Text] [Related]
37. The effect of a low-fat diet on hormone levels in healthy pre- and postmenopausal women: relevance for breast cancer.
Crighton IL; Dowsett M; Hunter M; Shaw C; Smith IE
Eur J Cancer; 1992; 28A(12):2024-7. PubMed ID: 1419300
[TBL] [Abstract][Full Text] [Related]
38. Prolactin concentrations in patients with breast cancer.
Franks S; Ralphs DN; Seagroatt V; Jacobs HS
Br Med J; 1974 Nov; 4(5940):320-1. PubMed ID: 4434088
[TBL] [Abstract][Full Text] [Related]
39. Serum sex hormone levels in pre- and postmenopausal breast cancer patients.
Ho CC; Rohaizak M; Zulkifli SZ; Siti-Aishah MA; Nor-Aini U; Sharifah-Noor-Akmal SH
Singapore Med J; 2009 May; 50(5):513-8. PubMed ID: 19495523
[TBL] [Abstract][Full Text] [Related]
40. Prolactin levels in populations at risk for breast cancer.
Hill P; Wynder EL; Kumar H; Helman P; Rona G; Kuno K
Cancer Res; 1976 Nov; 36(11 Pt 1):4102-6. PubMed ID: 975051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
